NASDAQ: VSEEVsee Health Inc Stock
$0.45-0.02 (-4.26%)
Updated Dec 16, 2025
VSEE Price
$0.45
Fair Value Price
N/A
Market Cap
$14.11M
52 Week Low
$0.45
52 Week High
$2.52
P/E
2.65x
P/B
-2.53x
P/S
0.69x
PEG
N/A
Dividend Yield
N/A
Revenue
$14.55M
Earnings
-$12.48M
Gross Margin
54.6%
Operating Margin
-68.49%
Profit Margin
-85.8%
Debt to Equity
-4.36
Operating Cash Flow
-$4M
Beta
0.33
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
VSEE Overview
Digital Health Acquisition Corp. is a "blank check" company formed to effect mergers, share exchanges, asset acquisitions, share purchases, reorganizations, or similar business combinations. It targets technology and healthcare-focused businesses. Digital Health Acquisition was incorporated in 2021 and is based in Boca Raton, FL.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine VSEE's potential to beat the market
- VSEE doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Health Information Service
Industry Rating
B
VSEE
RankedUnranked of 44
RankedUnranked of 44
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $22.25 | A | |
| $171.72 | A | |
| $12.77 | A |
Be the first to know about important VSEE news, forecast changes, insider trades & much more!
VSEE News
Overview
Due Diligence Score
–
Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how VSEE scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
VSEE is good value based on its earnings relative to its share price (2.65x), compared to the US market average (45.32x)
P/E vs Market Valuation
VSEE is good value based on its earnings relative to its share price (2.65x), compared to the US Health Information Services industry average (42.53x)
P/E vs Industry Valuation
VSEE's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more VSEE due diligence checks available for Premium users.
Valuation
VSEE price to earnings (PE)
For valuing profitable companies with steady earnings
Company
2.65x
Industry
42.53x
Market
45.32x
VSEE is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
VSEE is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
VSEE price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-2.53x
Industry
3.92x
VSEE's financial health
Profit margin
Revenue
$4.0M
Net Income
-$289.7k
Profit Margin
-7.3%
VSEE's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
VSEE's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$18.7M
Liabilities
$24.3M
Debt to equity
-4.36
VSEE's short-term liabilities ($23.42M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
VSEE's short-term assets ($3.72M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
VSEE's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
VSEE's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$754.5k
Investing
-$7.3k
Financing
$943.0k
VSEE's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
VSEE vs Health Information Service Stocks
Vsee Health Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.